Four weeks after receiving monitored doses of psilocybin, researchers reported more than half of the study's 24 participants had achieved remission from their depression.
Four weeks after receiving monitored doses of psilocybin, researchers reported more than half of the study's 24 participants had achieved remission from their depression.